1251264-73-9

Basic information

• Product Name: 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine
• Synonyms: 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine
• CAS NO: 1251264-73-9
• Molecular Weight: 227.189
• Mol File: 1251264-73-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine(1251264-73-9)
• EPA Substance Registry System: 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine(1251264-73-9)

Safety Data

• Hazardous Substances Data: 1251264-73-9(Hazardous Substances Data)

Usage

General Description

1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine is a chemical compound with a molecular formula C9H7F3N4. It belongs to the class of pyrazole compounds and consists of a pyrazole ring with a trifluoromethylphenyl group and an amine group. 1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-amine is used in the development of pharmaceutical drugs and is being studied for its potential therapeutic properties. Its unique chemical structure makes it a valuable building block for the synthesis of various bioactive compounds and serves as a starting point for medicinal chemistry research. The trifluoromethyl group in the compound also imparts unique properties that may be useful in drug design and discovery.

Upstream product

• 402-43-7 p-trifluoromethylphenyl bromide 
• 1013-88-3 Benzophenone imine 
• 1203556-18-6 4-bromo-1-(4-(trifluoromethyl)phenyl)-1H-pyrazole 
• 207797-05-5 1-(4-trifluoromethyl-phenyl)-1H-pyrazole 
• 402-44-8 4-Fluorobenzotrifluoride 
• 128796-39-4 4-trifluoromethylphenylboronic acid 
• 1355534-07-4 4-nitro-1-(4-trifluoromethyl-phenyl)-1H-pyrazole 

Downstream Products

• 1355534-16-5 C₂₅H₂₈F₃N₃O₂ 
• 1355534-20-1 C₂₁H₂₀F₃N₃O₂ 
• 1355534-24-5 C₂₆H₂₉F₃N₄O₃ 
• 1401993-78-9 8-ethyl-3-methyl-2-oxo-N-{1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}-1-oxa-8-azaspiro[4.5]dec-3-ene-4-carboxamide 

Relevant articles and documents

Design and synthesis of anti-tumor compounds containing ferulic acid-pyrazole skeleton

The invention discloses design and a preparation method of an anti-tumor compound containing a ferulic acid-pyrazole skeleton. The structure of the anti-tumor compound is shown as a formula in the specification.

Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators

The present invention is directed to compounds of Formula (I) below, which are antagonists to the chemoattractant cytokine receptor 2 (CCR2), and/or 5 (CCR5), pharmaceutical compositions, and methods for use thereof.

A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity

A novel series of glucagon receptor antagonists has been discovered. These pyrazole ethers and aminopyrazoles have lower molecular weight and increased polarity such that the molecules fall into better drug-like property space. This work has culminated in